Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis ConsortiumKÖBEL, Martin; KALLOGER, Steve E; VIERKANT, Robert A et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 10, pp 1677-1686, issn 1055-9965, 10 p.Article

Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?HUNTER, Sally M; ANGLESIO, Michael S; CAMPBELL, Ian G et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7273-7282, issn 1078-0432, 10 p.Article

De novo expression of CD44 variants in sporadic and hereditary gastric cancerBRANCO DA CUNHA, Cristiana; OLIVEIRA, Carla; SERUCA, Raquel et al.Laboratory investigation. 2010, Vol 90, Num 11, pp 1604-1614, issn 0023-6837, 11 p.Article

Hereditary Diffuse Gastric Cancer : Diagnosis, Genetic Counseling, and Prophylactic Total GastrectomyLYNCH, Henry T; KAURAH, Pardeep; WIRTZFELD, Debrah et al.Cancer. 2008, Vol 112, Num 12, pp 2655-2663, issn 0008-543X, 9 p.Article

CDH1 truncating mutations in the E-cadherin gene: An indication for total gastrectomy to treat hereditary diffuse gastric cancerNORTON, Jeffrey A; HAM, Christine M; VAN DAM, Jacques et al.Annals of surgery. 2007, Vol 245, Num 6, pp 873-879, issn 0003-4932, 7 p.Article

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarrayPARKER, Robin L; HUNTSMAN, David G; LESACK, David W et al.American journal of clinical pathology. 2002, Vol 117, Num 5, pp 723-728, issn 0002-9173Article

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer: Utility of a Histology-Based Referral StrategySCHRADER, Kasmintan A; HURLBURT, Jane; KALLOGER, Steve E et al.Obstetrics and gynecology (New York. 1953). 2012, Vol 120, Num 2, pp 235-240, issn 0029-7844, 6 p., 1Article

The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancerSPOWART, Jaeline E; TOWNSEND, Katelin N; GILKS, C. Blake et al.Journal of pathology (Print). 2012, Vol 228, Num 4, pp 437-447, issn 0022-3417, 11 p.Article

Use of mutation profiles to refine the classification of endometrial carcinomasMCCONECHY, Melissa K; JIARUI DING; MCDONALD, Helen et al.Journal of pathology (Print). 2012, Vol 228, Num 1, pp 20-30, issn 0022-3417, 11 p.Article

Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancersBROWN, Lindsay A; JOHNSON, Karynn; LEUNG, Samuel et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 347-354, issn 0167-6806, 8 p.Article

Differential subcellular expression of protein kinase C betall in breast cancer: correlation with breast cancer subtypesGÖKMEN-POLAR, Yesim; MEHTA, Rutika; BADVE, Sunil et al.Breast cancer research and treatment. 2010, Vol 124, Num 2, pp 327-335, issn 0167-6806, 9 p.Article

PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor―Positive Breast CancerCROWDER, Robert J; PHOMMALY, Chanpheng; SNIDER, Jacqueline et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3955-3962, issn 0008-5472, 8 p.Article

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYINGHUI GUAN; KUO, Wen-Lin; KALLOGER, Steve E et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5745-5755, issn 1078-0432, 11 p.Article

Characterization of a recurrent germ line mutation of the E-Cadherin gene : Implications for genetic testing and clinical managementSURIANO, Gianpaolo; YEW, Sandie; OLIVEIRA, Maria J et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5401-5409, issn 1078-0432, 9 p.Article

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell CancerANGLESIO, Michael S; GEORGE, Joshy; CHAKRAVARTY, Probir et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2538-2548, issn 1078-0432, 11 p.Article

Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesSCHRADER, Kasmintan A; HERAVI-MOUSSAVI, Alireza; BOYD, Niki et al.Journal of pathology (Print). 2011, Vol 225, Num 1, pp 12-18, issn 0022-3417, 7 p.Article

ARID1A Mutations in Endometriosis-Associated Ovarian CarcinomasWIEGAND, Kimberly C; SHAH, Sohrab P; YANG, Winnie et al.The New England journal of medicine. 2010, Vol 363, Num 16, pp 1532-1543, issn 0028-4793, 12 p.Article

Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian StudyKÖBEL, Martin; KALLOGER, Steve E; PARKER, Robin et al.The American journal of surgical pathology. 2010, Vol 34, Num 7, pp 984-993, issn 0147-5185, 10 p.Article

Identification of sister chromatids by DNA template strand sequencesFALCONER, Ester; CHAVEZ, Elizabeth A; HENDERSON, Alexander et al.Nature (London). 2010, Vol 463, Num 7277, pp 93-97, issn 0028-0836, 5 p.Article

Mutation of FOXL2 in Granulosa-Cell Tumors of the OvarySHAH, Sohrab P; KÖBEL, Martin; SUN, Mark et al.The New England journal of medicine. 2009, Vol 360, Num 26, pp 2719-2729, issn 0028-4793, 11 p.Article

Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1) : Pathologic Findings With Clinical ImplicationsROGERS, William M; DOBO, Erika; NORTON, Jeffrey A et al.The American journal of surgical pathology. 2008, Vol 32, Num 6, pp 799-809, issn 0147-5185, 11 p.Article

Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancerKULKARNI, Geeta; TURBIN, Dmitry A; AMIRI, Anahita et al.Breast cancer research and treatment. 2007, Vol 102, Num 1, pp 31-41, issn 0167-6806, 11 p.Article

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast Cancer is associated with poor survival: Potential for intervention with 17-allylamino geldanamycinNIELSEN, Torsten O; ANDREWS, Heather N; NECKERS, Leonard M et al.Cancer research (Baltimore). 2004, Vol 64, Num 1, pp 286-291, issn 0008-5472, 6 p.Article

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasANGLESIO, Michael S; KOMMOSS, Stefan; SENZ, Janine et al.Journal of pathology (Print). 2013, Vol 229, Num 1, pp 111-120, issn 0022-3417, 10 p.Article

Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian CancersHERAVI-MOUSSAVI, Alireza; ANGLESIO, Michael S; HAMEL, Nancy et al.The New England journal of medicine. 2012, Vol 366, Num 3, pp 234-242, issn 0028-4793, 9 p.Article